These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11298525)

  • 1. Mastocytosis: recent advances in defining the disease.
    Hartmann K; Henz BM
    Br J Dermatol; 2001 Apr; 144(4):682-95. PubMed ID: 11298525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis.
    Wiechers T; Rabenhorst A; Schick T; Preussner LM; Förster A; Valent P; Horny HP; Sotlar K; Hartmann K
    J Allergy Clin Immunol; 2015 Dec; 136(6):1581-1590.e3. PubMed ID: 26152315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric mastocytosis.
    Hartmann K; Metcalfe DD
    Hematol Oncol Clin North Am; 2000 Jun; 14(3):625-40. PubMed ID: 10909043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cutaneous mastocytosis].
    Flageul B
    Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior.
    Büttner C; Henz BM; Welker P; Sepp NT; Grabbe J
    J Invest Dermatol; 1998 Dec; 111(6):1227-31. PubMed ID: 9856847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial urticaria pigmentosa: report of a family and review of the role of KIT mutations.
    Fett NM; Teng J; Longley BJ
    Am J Dermatopathol; 2013 Feb; 35(1):113-6. PubMed ID: 22892471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
    Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I
    Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric mastocytosis: long-term follow-up of 53 patients with whole sequencing of KIT. A prospective study.
    Meni C; Georgin-Lavialle S; Le Saché de Peufeilhoux L; Jais JP; Hadj-Rabia S; Bruneau J; Fraitag S; Hanssens K; Dubreuil P; Hermine O; Bodemer C
    Br J Dermatol; 2018 Oct; 179(4):925-932. PubMed ID: 29787623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mastocytosis: review of clinical and experimental aspects.
    Hartmann K; Bruns SB; Henz BM
    J Investig Dermatol Symp Proc; 2001 Nov; 6(2):143-7. PubMed ID: 11764303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel R634W c-kit mutation identified in familial mastocytosis.
    Pollard WL; Beachkofsky TM; Kobayashi TT
    Pediatr Dermatol; 2015; 32(2):267-70. PubMed ID: 25243845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R634W KIT Mutation in an Adult With Systemic Mastocytosis.
    Astle JM; Rose MG; Racke FK; Tormey CA; Siddon AJ
    Lab Med; 2017 Aug; 48(3):253-257. PubMed ID: 28520972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the pathogenesis, diagnosis, and management of mastocytosis.
    Fuller SJ
    Hematol Oncol Clin North Am; 2012 Dec; 26(6):1143-68. PubMed ID: 23116574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Mastocytosis (Part 1): Pathophysiology, Clinical Features, and Diagnosis.
    Azaña JM; Torrelo A; Matito A
    Actas Dermosifiliogr; 2016; 107(1):5-14. PubMed ID: 26546030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastocytosis: a comprehensive insight.
    VAN Gysel D; DE Maeseneer H; Oranje AP
    G Ital Dermatol Venereol; 2016 Aug; 151(4):385-96. PubMed ID: 27070304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis.
    Hartmann K; Hermes B; Rappersberger K; Sepp N; Mekori YA; Henz BM
    Br J Dermatol; 2003 Sep; 149(3):554-9. PubMed ID: 14510988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mastocytosis and the skin.
    Soter NA
    Hematol Oncol Clin North Am; 2000 Jun; 14(3):537-55, vi. PubMed ID: 10909039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.
    Longley BJ; Metcalfe DD; Tharp M; Wang X; Tyrrell L; Lu SZ; Heitjan D; Ma Y
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1609-14. PubMed ID: 9990072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mastocytosis: classification, diagnosis, and clinical presentation.
    Castells MC
    Allergy Asthma Proc; 2004; 25(1):33-6. PubMed ID: 15055560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.